EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with Vaxzevria (previously COVID-19 Vaccine AstraZeneca) at its extraordinary meeting of 18 March 2021. The Committee confirmed that: the benefits of the vaccine in combating the still widespread threat of COVID-19 (which itself results in clotting problems and maybe fatal) continue …

